HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

In this episode, we discuss newly approved agents for diabetes mellitus: Afrezza (inhaled human insulin), SGLT2 inhibitors (Invokana, Farxiga, Jardiance), and long-acting GLP-1 agonists (Bydureon, Tanzeum).

Direct download: 016_-_New_DM_Agents.mp3
Category:general -- posted at: 6:00am EST

1